Latest Insurance Claims News

Foresta Group Holdings has finalized a $4.6 million insurance settlement related to 2021 asset damage at Apple Tree Creek, marking the close of a multi-year claim process.

Timah Resources Limited reported a 13% revenue decline in H1 2025, impacted by a significant flashover incident at its Biogas Power Plant that disrupted power exports and delayed operations.

Star Combo Pharma has reported a remarkable jump in profit for FY2025, driven by strong revenue growth and a settled insurance claim, while declaring its second dividend and planning production expansion.

Livium Ltd reports a significant A$6.6 million uplift in net assets driven by a reduction in fire claim provisions, recognition of a deferred tax asset, and equity accounting of its LieNA® joint venture with Mineral Resources.

Fletcher Building reported a $419 million net loss for FY25 on softer demand and legacy costs but halved its net debt to $999 million through strategic capital management and divestments.

Cleo Diagnostics has launched a health economic study in partnership with EntityRisk and Norstella to support the U.S. market entry of its Ovarian Cancer Pre-Surgical Test, aiming to refine reimbursement strategies and accelerate commercialisation.

Foresta Group Holdings secures a critical extension from New Zealand's Overseas Investment Office and partners with EECA to explore geothermal energy use, pushing forward its flagship Kawerau biomass project.

SIV Capital Limited reported a positive net cash flow for Q4 FY25 and holds $8.177 million in cash, while evaluating a new acquisition opportunity despite ongoing ASX suspension.

Livium Ltd reported a modest net profit in its battery recycling division for Q4 FY25, while securing significant new contracts and progressing lithium extraction technology development.

Otto Energy has completed a $38.4 million capital return while maintaining steady oil production despite a dip in gas output. The company also announced the resignation of its Acting CEO, signaling a period of transition.

dorsaVi has acquired exclusive global rights to advanced RRAM technology, promising major performance gains in its biomedical sensors, while securing key contracts and raising $2.44 million to fuel US market growth.

Korvest has reported record full-year earnings for FY25, driven by a surge in major project revenue and strong cash flow, while approving a significant expansion of its Kilburn manufacturing facility.